AGIOS PHARMACEUTICALS, INC. (AGIO)
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Address
88 SIDNEY STREET
CAMBRIDGE, MA 02139
Founded
2007
Number of Employees
383
Website
http://www.agios.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | $802,460 | - | - | - | $802,460 |
| Average Price | - | - | - | - | - | - | - | $49.48 | - | - | - | $49.48 |
| # Shares Purchased | - | - | - | - | - | - | - | 16,216,411 | - | - | - | 16,216,411 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | -7.0% | - | - | - | -7.0% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | - | - | - | 31.7% |
| Excess Total Return | - | - | - | - | - | - | - | -38.7% | - | - | - | -38.7% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | 40% | - | - | - | 37% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at AGIO make a trade.
Creating a free account takes less than one minute